Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01650831 · ClinicalTrials.gov registry record · NA
Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection
A NA study of Suspicion of Being Infected With H.Pylori, sponsored by Meridian Bioscience.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
- 1
- Study location
NCT01650831 is a NA study of Suspicion of Being Infected With H.Pylori that has completed, run by Meridian Bioscience. The registered enrollment target is 113 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01650831, a NA study of Suspicion of Being Infected With H.Pylori, has completed, sponsored by Meridian Bioscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to confirm equivalence of a new generation breath analyzer (Modified BreathID) in its ability to detect H. pylori compared to the currently approved BreathID® System.
Conditions Studied
Interventions
- DEVICE Modified BreathID
Study Locations (1)
New Jersey
- Unimed Center - East Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01650831
The ClinicalTrials.gov registry entry for NCT01650831 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meridian Bioscience, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suspicion of Being Infected With H.Pylori appearing as the primary indexed condition, and to 1 intervention - of which Modified BreathID is the first listed.
NCT01650831 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT01650831 about?
NCT01650831 is a clinical study titled "Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection". The purpose of this study is to confirm equivalence of a new generation breath analyzer (Modified BreathID) in its ability to detect H. pylori compared to the currently approved BreathID® System.
What is the current status of trial NCT01650831?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2012-10. Estimated completion is 2013-01.
What conditions does trial NCT01650831 study?
This clinical trial studies the following conditions: Suspicion of Being Infected With H.Pylori.
What interventions are being tested in trial NCT01650831?
The interventions under investigation include: Modified BreathID (DEVICE).
Who is sponsoring clinical trial NCT01650831?
This trial is sponsored by Meridian Bioscience, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01650831 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.